{"id":"imiglucerase-gz437843","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Arthralgia"},{"rate":null,"effect":"Fever"}]},"_chembl":{"chemblId":"CHEMBL1201632","moleculeType":"Enzyme"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Imiglucerase is an enzyme replacement therapy that provides functional glucocerebrosidase to patients with Gaucher disease, a lysosomal storage disorder caused by deficiency of this enzyme. By catalyzing the hydrolysis of glucocerebroside to glucose and ceramide, it reduces pathological lipid accumulation in macrophages and other tissues, thereby alleviating disease manifestations.","oneSentence":"Imiglucerase is a recombinant glucocerebrosidase enzyme that breaks down glucocerebroside, a lipid that accumulates in Gaucher disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:15:35.058Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gaucher disease type 1"},{"name":"Gaucher disease type 3"}]},"trialDetails":[{"nctId":"NCT03485677","phase":"PHASE3","title":"Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-04-11","conditions":"Gaucher's Disease Type I, Gaucher's Disease Type III","enrollment":57}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cerezyme"],"phase":"phase_3","status":"active","brandName":"Imiglucerase GZ437843","genericName":"Imiglucerase GZ437843","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Imiglucerase is a recombinant glucocerebrosidase enzyme that breaks down glucocerebroside, a lipid that accumulates in Gaucher disease. Used for Gaucher disease type 1, Gaucher disease type 3.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}